Mary D. Ruppe

2.2k total citations
24 papers, 1.4k citations indexed

About

Mary D. Ruppe is a scholar working on Nephrology, Oncology and Genetics. According to data from OpenAlex, Mary D. Ruppe has authored 24 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Nephrology, 7 papers in Oncology and 6 papers in Genetics. Recurrent topics in Mary D. Ruppe's work include Parathyroid Disorders and Treatments (11 papers), Bone health and treatments (4 papers) and Magnesium in Health and Disease (4 papers). Mary D. Ruppe is often cited by papers focused on Parathyroid Disorders and Treatments (11 papers), Bone health and treatments (4 papers) and Magnesium in Health and Disease (4 papers). Mary D. Ruppe collaborates with scholars based in United States, Canada and France. Mary D. Ruppe's co-authors include Lennart Mucke, Edward Rockenstein, Eliezer Masliah, Stephanie M. Toggas, Mark A. Klausner, Jeffrey S. Humphrey, Munro Peacock, Laila Tabatabai, Karl Insogna and Erik A. Imel and has published in prestigious journals such as Journal of Clinical Investigation, The Journal of Experimental Medicine and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Mary D. Ruppe

23 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mary D. Ruppe United States 16 446 385 319 221 214 24 1.4k
Anna Mazzeo Italy 25 202 0.5× 1.1k 3.0× 263 0.8× 166 0.8× 360 1.7× 86 1.9k
Sigrid Hoffmann Germany 24 298 0.7× 995 2.6× 125 0.4× 86 0.4× 113 0.5× 63 2.0k
Sherry L. Abboud‐Werner United States 13 65 0.1× 353 0.9× 392 1.2× 168 0.8× 183 0.9× 16 1.0k
Ivo Quack Germany 22 515 1.2× 593 1.5× 220 0.7× 166 0.8× 36 0.2× 56 1.9k
James M. Dominguez United States 23 78 0.2× 476 1.2× 307 1.0× 73 0.3× 69 0.3× 42 1.3k
Axel Regeniter Switzerland 18 108 0.2× 377 1.0× 272 0.9× 97 0.4× 135 0.6× 41 1.5k
Mathias Chiano United Kingdom 15 116 0.3× 677 1.8× 129 0.4× 123 0.6× 200 0.9× 26 1.3k
Aaron L. Magno Australia 17 164 0.4× 642 1.7× 122 0.4× 97 0.4× 52 0.2× 32 1.2k
A Micheli Italy 15 81 0.2× 201 0.5× 107 0.3× 136 0.6× 92 0.4× 27 1.1k
Akihiro Sakurai Japan 23 260 0.6× 621 1.6× 165 0.5× 826 3.7× 48 0.2× 122 2.8k

Countries citing papers authored by Mary D. Ruppe

Since Specialization
Citations

This map shows the geographic impact of Mary D. Ruppe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary D. Ruppe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary D. Ruppe more than expected).

Fields of papers citing papers by Mary D. Ruppe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary D. Ruppe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary D. Ruppe. The network helps show where Mary D. Ruppe may publish in the future.

Co-authorship network of co-authors of Mary D. Ruppe

This figure shows the co-authorship network connecting the top 25 collaborators of Mary D. Ruppe. A scholar is included among the top collaborators of Mary D. Ruppe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary D. Ruppe. Mary D. Ruppe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Murphy, Eileen, et al.. (2018). Co-morbidity with hypertrophic osteoarthropathy: A possible Iron Age Sarmatian case from the Volga steppe of Russia. International Journal of Paleopathology. 24. 66–78. 1 indexed citations
2.
Ruppe, Mary D., et al.. (2017). The Parathyroid Gland and Heart Disease. Methodist DeBakey Cardiovascular Journal. 13(2). 49–49. 75 indexed citations
3.
Zhang, Xiaoping, Erik A. Imel, Mary D. Ruppe, et al.. (2016). Pharmacokinetics and pharmacodynamics of a human monoclonal anti‐FGF23 antibody (KRN23) in the first multiple ascending‐dose trial treating adults with X‐linked hypophosphatemia. Publisher. 1 indexed citations
4.
Ruppe, Mary D., Xiaoping Zhang, Erik A. Imel, et al.. (2016). Effect of four monthly doses of a human monoclonal anti-FGF23 antibody (KRN23) on quality of life in X-linked hypophosphatemia. Bone Reports. 5. 158–162. 44 indexed citations
6.
Imel, Erik A., Xiaoping Zhang, Mary D. Ruppe, et al.. (2015). Prolonged Correction of Serum Phosphorus in Adults With X-Linked Hypophosphatemia Using Monthly Doses of KRN23. The Journal of Clinical Endocrinology & Metabolism. 100(7). 2565–2573. 114 indexed citations
7.
Zhang, Xiaoping, Erik A. Imel, Mary D. Ruppe, et al.. (2015). Pharmacokinetics and pharmacodynamics of a human monoclonal anti‐FGF23 antibody (KRN23) in the first multiple ascending‐dose trial treating adults with X‐linked hypophosphatemia. The Journal of Clinical Pharmacology. 56(2). 176–185. 41 indexed citations
8.
Ruppe, Mary D., Xiao–Ping Zhang, Erik A. Imel, et al.. (2014). Assessment of Quality of Life Data After 4 Monthly S.C. Doses of a Human Monoclonal Anti-Fibroblast Growth Factor 23 Antibody (KRN23) in Adults with X-linked Hypophosphatemia. 82. 1 indexed citations
9.
Carpenter, Thomas O., Erik A. Imel, Mary D. Ruppe, et al.. (2014). Randomized trial of the anti-FGF23 antibody KRN23 in X-linked hypophosphatemia. Journal of Clinical Investigation. 124(4). 1587–1597. 215 indexed citations
10.
Ruppe, Mary D.. (2014). X-Linked Hypophosphatemia. 8 indexed citations
11.
Landry, Christine S., Mary D. Ruppe, & Elizabeth G. Grubbs. (2011). Vitamin D Receptors And Parathyroid Glands. Endocrine Practice. 17. 63–68. 17 indexed citations
12.
Rios, Adan, et al.. (2011). Kaposi Sarcoma in the Setting of Cushing Disease. Endocrine Practice. 17(4). e87–e91. 1 indexed citations
13.
Ruppe, Mary D., et al.. (2010). Mutational analysis of PHEX, FGF23 and DMP1 in a cohort of patients with hypophosphatemic rickets. Clinical Endocrinology. 74(3). 312–318. 47 indexed citations
14.
Ruppe, Mary D.. (2010). Medications That Affect Calcium. Endocrine Practice. 17. 26–30. 16 indexed citations
15.
Ruppe, Mary D., Stephen A. Huang, & Suzanne M. Jan de Beur. (2005). Consumptive Hypothyroidism Caused by Paraneoplastic Production of Type 3 Iodothyronine Deiodinase. Thyroid. 15(12). 1369–1372. 34 indexed citations
16.
Brown, Todd T., Mary D. Ruppe, Princy Kumar, et al.. (2004). Reduced Bone Mineral Density in Human Immunodeficiency Virus-Infected Patients and Its Association with Increased Central Adiposity and Postload Hyperglycemia. The Journal of Clinical Endocrinology & Metabolism. 89(3). 1200–1206. 93 indexed citations
17.
Johnson, William B., Mary D. Ruppe, Edward Rockenstein, et al.. (1995). Indicator expression directed by regulatory sequences of the glial fibrillary acidic protein (GFAP) gene: In vivo comparison of distinct GFAP‐lacZ transgenes. Glia. 13(3). 174–184. 76 indexed citations
18.
Borrow, Persephone, et al.. (1995). Immunization-induced inflammatory infiltration of the central nervous system in transgenic mice expressing a microbial antigen in astrocytes. Journal of Neuroimmunology. 61(2). 133–149. 15 indexed citations
19.
Mucke, Lennart, Carmela R. Abraham, Mary D. Ruppe, et al.. (1995). Protection against HIV-1 gp120-induced brain damage by neuronal expression of human amyloid precursor protein.. The Journal of Experimental Medicine. 181(4). 1551–1556. 74 indexed citations
20.
Mucke, Lennart, Eliezer Masliah, William B. Johnson, et al.. (1994). Synaptotrophic effects of human amyloid β protein precursors in the cortex of transgenic mice. Brain Research. 666(2). 151–167. 234 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026